Abstract
Objective
To investigate the expression of motilin-immunoreactive neurons in the hypothalamus and the effect of central administration of erythromycin (EM) on the regulation of gastric motility in diabetic rats.
Methods
The motilin immunoreactive neurons in the hypothalamus and the hippocampus were detected by immunohistochemistry with rabbit anti-motilin polyclonal antibody. To measure the gastric motility, force transducers were surgically affixed to the gastric serosa. A microinjection syringe was connected via a plastic tube to an injection cannula, which was connected with a stainless steel guide cannula. The syringe was inserted into the right lateral cerebral ventricle for microinjecting the chemicals.
Results
Diabetic mellitus was successfully induced in cohorts of rats. Motilin-immunoreactive neurons significantly increased in the paraventricular (PVN) and supraoptic nuclei (SON) of the hypothalamus in the diabetic rats. Intracerebroventricular (i.c.v.) administration of EM, a motilin receptor agonist, stimulated the gastric motility of diabetic rats. EM (91.56 nmol, i.c.v.) dose-dependently increased the amplitude by (174.82±48.62)% (P < 0.05), and increased the frequency by (70.43±27.11)% (P < 0.05) in 5 min. The stimulatory effect lasted more than 15 min to the end of the measurement, and can be blocked partially by the prior treatment of motilin receptor antagonist GM-109.
Conclusion
Motilin-immunoreactive neurons are increased in the PVN and SON of the hypothalamus in diabetic rats. Centrally administered EM may regulate gastric motility by binding to the central motilin receptors, and central motilin might be involved in regulation of gastric motility in diabetic rats.
摘要
目的
以往的研究表明胃动素存在于大鼠的中枢神经系统, 在中枢注射胃动素具有促进清醒大鼠胃运动的作用。 但糖尿病大鼠中枢胃动素表达含量及中枢注射胃动素对糖尿病大鼠胃运动的潜在作用目前尚未报导。 本研究探索糖尿病大鼠胃动素免疫阳性神经元在下丘脑的表达, 观察侧脑室微量注射胃动素受体激动剂红霉素(erythromycin, EM)对**常和糖尿病大鼠胃运动的作用。
方法
采用免疫组织化学方法测定下丘脑胃动素免疫阳性神经元的分布特征。 在胃窦浆膜层植入应力传感器, 测定清醒大鼠胃运动的幅度和频率。
结果
糖尿病大鼠下丘脑室旁核和视上核胃动素免疫阳性神经元数量明显高于**常对照大鼠(P < 0.05)。 脑室内微量注射EM可以明显促进糖尿病大鼠的胃运动。 注射91.56 nmol的EM五分钟后, 大鼠胃窦运动幅度升高(174.82 ± 48.62)% (P < 0.05), 运动频率加快(70.43 ± 27.11)% (P < 0.05)。 在脑室内微量注射胃动素拮抗剂GM-109后, 再注射EM, 其促胃运动效应可被部分阻断。
结论
糖尿病大鼠中枢胃动素对胃运动有一定的调制作用, 而且脑室内微量注射的EM是通过脑内的胃动素受体介导而发挥其促胃动力效应。
Similar content being viewed by others
References
Itoh Z. Motilin and clinical application. Peptides 1997, 18: 593–608.
Xu L, Depoortere I, Tang M, Peeters TL. Identification and expression of the motilin precursor in the guinea pig. FEBS Lett 2001, 490: 7–10.
Depoortere I, Van Assche G, Peeters TL. Distribution and subcellular localization of motilin binding sites in the rabbit brain. Brain Res 1997, 777: 103–109.
Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983, 98: 378–384.
Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJ. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991, 18: 229–234.
Chen J, McCallum RW. Gastric slow wave abnormalities in patients with gastroparesis. Am J Gastroenterol 1992, 87: 477–482.
Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993, 105: 1886–1899.
Ueno N, Inui A, Asakawa A, Takao F, Tani S, Komatsu Y, et al. Erythromycin improves glycaemic control in patients with Type II diabetes mellitus. Diabetologia 2000, 43: 411–415.
Peeters TL. New motilin agonists: a long and winding road. Neurogastroenterol Motil 2006, 18: 1–5.
Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 1990, 322: 1028–1031.
Lin L, Ji M, Zhang HJ, Lin Z, Zhao ZQ. Effect of erythromycin on gastric dysmotility and neuroendocrine peptides in rats with diabetes mellitus. Chin Med Sci J 2005, 20: 176–180.
Schmid R, Schusdziarra V, Allescher HD, Bofilias I, Buttermann G, Classen M. Effect of motilin on gastric emptying in patients with diabetic gastroparesis. Diabetes Care 1991, 14: 65–68.
Asakawa A, Inui A, Momose K, Ueno N, Fu**o MA, Kasuga M. Motilin increases food intake in mice. Peptides 1998, 19: 987–990.
Tang M, Zhang HY, Jiang ZY, Xu L, Peeters TL. Effect of central administration of motilin on the activity of gastricrelated neurons in brain stem and gastric motility of rats. Acta Physiol Sinica 2000, 52: 416–420.
Zhang AJ, Tang M, Jiang ZY. Administration of motilin into the lateral hypothalamus increases gastric antrum motility and activates the dorsal vagal complex in rats. Acta Physiol Sinica 2002, 54: 417–421.
Guan Y, Tang M, Jiang Z, Peeters TL. Excitatory effects of motilin in the hippocampus on gastric motility in rats. Brain Res 2003, 984: 33–41.
Bahnak BR, Gold AH. Effects of alloxan diabetes on the turnover of rat liver glycogen synthase. Comparison with liver phosphorylase. J Biol Chem 1982, 257: 8775–8780.
Nerurkar MA, Satav JG, Katyare SS. Insulin-dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart. Diabetologia 1988, 31: 119–122.
Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. New York: Academic Press, 1998.
Federiuk IF, Casey HM, Quinn MJ, Wood MD, Ward WK. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Comp Med 2004, 54: 252–257.
Momose K, Inui A, Asakawa A, Ueno N, Nakajima M, Kasuga M. Anxiolytic effect of motilin and reversal with GM-109, a motilin antagonist, in mice. Peptides. 1998, 19: 1739–1742.
Plotsky PM. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin diabetic male rats. Neuroendocrinology 1991, 53: 433–438.
Leidy JW Jr, Cugini CD Jr, Driscoll HK, Chertow BS. Time course of hypothalamic growth hormone-releasing hormone and somatostatin content in streptozocin diabetic rats: evidence for early changes in hypothalamic regulation. Brain Res 1995, 681: 84–90.
Fu M, Li X, Zhang M, **an Y. Increased expression of neuropeptide Y and its mRNA in STZ-diabetic rats. Chin Med J (Engl) 2002, 115: 690–695.
Morris MJ, Pavia JM. Increased endogenous noradrenaline and neuropeptide Y release from the hypothalamus of streptozotocin diabetic rats. Brain Res 2004, 1006: 100–106.
Poitras P, Trudel L, Lahaie RG, Pomier-Layrargue G. Motilinlike-immunoreactivity in intestine and brain of dog. Life Sci 1987, 40: 1391–1395.
Xu L, Depoortere I, Thielemans L, Huang Z, Tang M, Peeters TL. Sequence, distribution and quantification of the motilin precursor in the cat. Peptides 2003, 24: 1387–1395.
Nagase H, Nakajima A, Sekihara H, York DA, Bray GA. Regulation of feeding behavior, gastric emptying, and sympathetic nerve activity to interscapular brown adipose tissue by galanin and enterostatin: the involvement of vagal-central nervous system interactions. J Gastroenterol 2002, 37(Suppl 14): 118–127.
Makarenko IG, Meguid MM, Gatto L, Chen C, Ugrumov MV. Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Brain Res 2003, 961: 100–108.
Rowland NE, Farnbauch LJ, Robertson KL. Brain muscarinic receptor subtypes mediating water intake and Fos following cerebroventricular administration of bethanecol in rats. Psychopharmacology (Berl) 2003, 167: 174–179.
Xu L, Depoortere I, Vertongen P, Waelbroeck M, Robberecht P, Peeters TL. Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor. Biochem Pharmacol 2005, 70: 879–887.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jia, YD., Liu, CQ., Tang, M. et al. Expression of motilin in the hypothalamus and the effect of central erythromycin on gastric motility in diabetic rats. Neurosci. Bull. 23, 75–82 (2007). https://doi.org/10.1007/s12264-007-0011-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-007-0011-4